Sunil Jaiswal | Dermatology | Best Researcher Award

Published on by Global Academic Awards

Dr. Sunil Jaiswal | Dermatology | Best Researcher Award

Dr. Sunil Jaiswal, Chitwan Medical College, Nepal

Dr. Sunil Jaiswal is a Senior Lecturer and Consultant Dermatologist at Chitwan Medical College, specializing in Dermatology, Venereology, and Leprology. He holds editorial roles with Dermatology Practical and Conceptual, Wiley Clinical Case Reports, and Journal of Chitwan Medical College. With an MD in Dermatology (Distinction) and MBBS (First Division), he has published original research and case reports, contributing significantly to dermatological science. Dr. Jaiswal’s research interests span dermatopathology, hair disorders, immunobullous disorders, and dermoscopy. A recipient of several prestigious awards, he is an active member of global dermatology societies, continuing to advance research and clinical excellence. 🌟

Publication Profile

Orcid

Education 🎓

Dr. Sunil Jaiswal earned his Doctor of Medicine (MD) in Dermatology from the College of Medical Sciences and Teaching Hospital, Bharatpur, affiliated with Kathmandu University in 2024 with Distinction honors. Prior to that, he completed his MBBS from Nepalese Army Institute of Health Sciences under Tribhuvan University in 2019 with First Division. His education reflects rigorous academic training, consistently marked by excellence and awards. His dedication to clinical and research education has laid a strong foundation for his current success as a dermatologist, lecturer, editor, and active researcher in the field of dermatology and allied disciplines. 📚

Experience 🏥

Dr. Jaiswal has been serving as a Consultant Dermatologist at Chitwan Medical College for the past 11 months, while also working as a Senior Lecturer in the Department of Dermatology, Venereology, and Leprology. His editorial contributions include roles as Editorial Consultant for Dermatology Practical and Conceptual, Associate Editor for Wiley Clinical Case Reports, and Section Editor for the Journal of Chitwan Medical College. He is highly engaged in academic, clinical, and publishing activities, demonstrating a balanced professional portfolio. His experience reflects excellence in dermatological practice, education, and research dissemination at both national and international levels. 🩺

Awards and Honors 🏆

Dr. Sunil Jaiswal has earned multiple accolades, including the Chief of Army Staff Gold Medal for excellence in basic medical sciences (2014), Best Oral Paper Presenter at the 17th Annual SODVELON Conference (2023), and the Torrent Young Scholar Dermatology Award (2024). He is also the recipient of the Next Generation Dermatologist Recognition Award (2025) for ranking top in his MD Dermatology class. Additionally, he holds memberships in prestigious societies like ISPD, IDS, SODVELON, and the World Dermatology Collaboration Society, reflecting both national and global recognition of his contributions to dermatology and research. 🥇

Research Focus 🔬

Dr. Jaiswal’s research focuses on dermatopathology, hair disorders, immunobullous disorders, Hansen’s Disease, dermoscopy, and recent advances in dermatology. His scholarly work includes 4 original articles, 9 case reports, and 1 case image, alongside active conference participation nationally and internationally. His research approach integrates clinical insights with emerging diagnostic techniques, ensuring relevance to both patient care and scientific advancement. By contributing to academic publishing and participating in global dermatology forums, he continues to enrich knowledge in specialized dermatological fields, fostering innovation and improved patient outcomes in the discipline. 🧬

Publication Top Notes

📅 2025 | 📖 Case Image: Cutaneous Leiomyoma | 🔗 DOI: 10.1002/ccr3.70471

📅 2025 | 📖 Hyperkeratotic Plaque on soles with yellowish-orange hue (Preprint) | 🔗 DOI: 10.22541/au.174537724.44682085/v1

📅 2025 | 📖 Generalised Brown Papules (Preprint) | 🔗 DOI: 10.22541/au.174529084.46201293/v1

📅 2025 | 📖 Cutaneous Leiomyoma (Preprint) | 🔗 DOI: 10.22541/au.174255126.62952561/v1

📅 2025 | 📖 Unravelling the challenges of mycetoma: a case series highlighting diagnostic dilemmas and therapeutic triumphs | 🔗 DOI: 10.1093/skinhd/vzae017

📅 2024 | 📖 Late-onset juvenile xanthogranuloma: a case report | 🔗 DOI: 10.1111/IJD.17263

📅 2024 | 📖 Lymphocytic infiltration as a marker of disease severity in patients with bullous pemphigoid – A case series | 🔗 DOI: 10.1002/CCR3.9084

📅 2024 | 📖 Misuse of topical over-the-counter medication: A case report | 🔗 DOI: 10.1002/CCR3.8949

📅 2024 | 📖 Palmoplantar psoriasis: A clinicopathological correlation in a tertiary care hospital | 🔗 DOI: 10.1111/SRT.13882

📅 2024 | 📖 Granulosis Rubra Nasi: A Rare Dermatosis not Limited to Nose | 🔗 DOI: 10.1002/ski2.345

📅 2024 | 📖 Metabolic Syndrome in Patients with Lichen Planus: A Case-Control Study | 🔗 DOI: 10.1002/ski2.315

📅 2023 | 📖 Acquired trichorrhexis nodosa in association with hyperthyroidism | 🔗 DOI: 10.1111/IJD.16798

📅 2023 | 📖 Herpes zoster occurring over the site of tinea cruris – A case report based on T-cell exhaustion model | 🔗 DOI: 10.1002/CCR3.8067

📅 2023 | 📖 Recurrent toxic epidermal necrolysis with two different drugs in a patient with chronic kidney disease | 🔗 DOI: 10.1002/CCR3.8027

Fenohasina Rakotonandrasana | Dermatology | Best Researcher Award

Published on by Global Academic Awards

Dr. Fenohasina Rakotonandrasana | Dermatology | Best Researcher Award

Dr. Fenohasina Rakotonandrasana, University of Antananarivo, Madagascar

Dr. Fenohasina Rakotonandrasana is a Malagasy medical doctor specializing in dermatology and venereology. Born on January 6, 1997, in Maninday, Tuléar, Madagascar, she earned her MD from the Faculty of Medicine, University of Antananarivo, in 2023. Currently pursuing her specialization in Dermatology-Venereology at the same institution, she also completed a hospital internship in Dermatology at Hôpital Nord Franche-Comté, France. Known for her academic excellence, Dr. Rakotonandrasana is passionate about autoimmune blistering dermatoses. Fluent in French and German, she has obtained certifications such as DELF B2 and the Goethe-Zertifikat A1, showcasing her multilingual and multicultural proficiency. 🌍🩺

Publication Profile

Orcid

🎓 Education

Dr. Rakotonandrasana began her medical studies in 2014 at the Faculty of Medicine, University of Antananarivo, and earned her Doctor of Medicine degree in 2023. She is currently pursuing a specialization in Dermatology-Venereology at the same faculty since 2022. Her educational journey includes international language certifications: DELF B1 (2017) and DELF B2 (2023) from the Alliance Française, and the Goethe-Zertifikat A1 (2015) from the Centre Germano-Malagasy. She completed her secondary education with a scientific baccalaureate (series D, mention Bien) from Lycée Arcade Talatamaty in 2013. Her academic path reflects both scientific rigor and strong linguistic ability. 📚🌐

🏥 Experience

In 2024, Dr. Rakotonandrasana served as a hospital intern (faisant fonction d’interne) in Dermatology at Hôpital Nord Franche-Comté in Trévenans, France, gaining hands-on experience in managing dermatologic conditions in a clinical setting. She began her specialization in Dermatology-Venereology in 2022 at the Faculty of Medicine, University of Antananarivo, following her general medical training that started in 2014. Her academic background is complemented by clinical immersion in both Madagascar and France, allowing her to engage with diverse patient populations and acquire valuable expertise in diagnosis and treatment of complex dermatologic cases. 🌍💼🧴

🏆 Awards and Honors

Dr. Fenohasina Rakotonandrasana received the highest academic distinction, Très Honorable avec félicitations du jury, for her doctoral thesis titled “Aspects épidemio-cliniques des dermatoses bulleuses auto-immunes observées à l’USFR Dermatologie : 12 ans après”. The thesis was also nominated for a university thesis award, underscoring her academic excellence and contribution to dermatological research. Her consistent achievements include receiving “mention Bien” in the national scientific baccalaureate examination and excelling in certified language examinations. These accolades highlight her commitment to academic excellence, intellectual rigor, and dedication to advancing dermatological science in Madagascar and beyond. 🥇📖🏅

🔬 Research Focus

Dr. Rakotonandrasana’s research centers on autoimmune blistering dermatoses, as exemplified by her doctoral thesis analyzing twelve years of epidemiological and clinical data from the Dermatology Department at the University Hospital. Her work focuses on understanding the presentation, progression, and treatment outcomes of these rare but serious dermatologic conditions in the Malagasy population. She is interested in improving early diagnosis and management strategies, integrating both local clinical practice and international dermatologic standards. Her research aims to enhance patient care through evidence-based medicine and bridge clinical gaps in tropical dermatology. 🧪🧫💡

Publication Top Notes

📘 2025 | Association of Tralokinumab and Adalimumab: Good Tolerance and Efficacy in a Case of Severe Atopic Dermatitis and Juvenile Idiopathic Arthritis | JEADV Clinical Practice | Authors: F. Rakotonandrasana, E. Puzenat, A. Ducournau, D. Popescu | DOI: 10.1002/jvc2.70016 | 📊 Cited by: Pending 🔗

🔍 2023 | Facteurs associés à l’infestation de la gale: étude cas témoins sur 206 patients | Ann. Dermatol. Vénéréol. – FMC | Authors: V.N. Ralimalala et al., incl. F. Rakotonandrasana | DOI: 10.1016/j.fander.2023.09.099 | 📊 Cited by: Pending 🕷️

🩺 2023 | Bullous Hemorrhagic Dermatosis Induced by Enoxaparin: About a Case in Madagascar | Case Reports in Dermatol. Medicine | Authors: F. Rakotonandrasana et al. | DOI: 10.1155/2023/5710870 | 📊 Cited by: 1 💉

🧠 2022 | Un cas de dermatomyosite chez un homme | Ann. Dermatol. Vénéréol. – FMC | Authors: F. Rakotonandrasana et al. | DOI: 10.1016/j.fander.2022.09.013 | 📊 Cited by: 2 💪

Liza Takiya | Dermatology | Business and Academic Collaboration Award

Published on by Global Academic Awards

Dr. Liza Takiya | Dermatology | Business and Academic Collaboration Award

Senior Medical Director. Pfizer, United States

A seasoned professional with over 25 years of experience in clinical internal medicine and the pharmaceutical industry, specializing in dermatology, rheumatology, neuroscience, pain management, and women’s health. Known for scientific leadership in medical strategy planning and execution, including product launches and advisory boards.  Recognized for building relationships, strategic thinking, and delivering results, leading to multiple awards and promotions throughout a distinguished career.

Profile

scopus

Education🎓

Doctor of Pharmacy from the University of Maryland, 1997.  Completed an ASHP Accredited Ambulatory Care/Community Practice Residency at the University of Maryland School of Pharmacy, 1997-1998.  Pre-Pharmacy studies at the University of Maryland, College Park, 1991-1993.  Participated in numerous management and leadership training programs, enhancing skills in executive coaching and women in leadership.

Experience💼 

Currently a Senior Director of US Medical Affairs in Dermatology at Pfizer Inc., with previous roles in Global Product Development and various leadership positions in Medical Affairs.  Served as an Associate Professor of Clinical Pharmacy at the University of the Sciences in Philadelphia, fostering the next generation of pharmacy leaders. 🏥 Prior experience includes roles at CVS Pharmacy, enhancing clinical pharmacy practice across Maryland and Pennsylvania.

Awards and Honors🏆

Fellow of the College of Clinical Pharmacy, awarded in 2010. 🌟 Completed multiple prestigious leadership programs, including the LandIt Executive Coaching in 2021 and Florida International University Women Leaders Program in 2020.  Received various internal awards for exemplary performance and contributions in medical affairs at Pfizer. 🎖 Recognized for her commitment to advancing women’s leadership in pharmacy and healthcare.

Research Focus🔬

Focused on medical strategy development and execution in dermatology, rheumatology, and neuroscience.  Research interests include product launches, field training, medical content creation, and clinical guidelines.  Committed to enhancing patient care through innovative pharmaceutical solutions and impactful educational initiatives.  Engages in community development through research and training aimed at addressing healthcare disparities.

Conclusion

In summary, the candidate is highly suitable for the Research for Business and Academic Collaboration Award due to their extensive clinical and pharmaceutical experience, demonstrated leadership, and commitment to education. While there are areas for improvement, such as expanding their research network and enhancing publication efforts, their strengths outweigh these areas. The candidate’s potential to drive impactful collaborations between academia and industry makes them a deserving nominee for this award.

Publication

1. Efficacy and Safety of Ritlecitinib in Alopecia Totalis and Alopecia Universalis

Authors: Mesinkovska, N., King, B., Zhang, X., Wolk, R., Schaefer, G.
Journal: Journal of Dermatology, 2024
Overview: This study evaluates the efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, specifically in adolescents and adults suffering from alopecia totalis and universalis. The findings indicate promising outcomes in hair regrowth and tolerability, marking a significant advancement in treatment options for severe forms of alopecia.
Citations: 0

2. Efficacy and Safety of Ritlecitinib in Adolescents with Alopecia Areata

Authors: Hordinsky, M., Hebert, A.A., Gooderham, M., Wolk, R., Tran, H.
Journal: Pediatric Dermatology, 2023, 40(6), pp. 1003–1009
Overview: This article reports on the results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial, highlighting the effectiveness of ritlecitinib in treating adolescents with alopecia areata. The study reveals significant improvements in hair regrowth compared to the placebo group.
Citations: 14

3. Overview of Alopecia Areata for Managed Care and Payer Stakeholders

Authors: King, B., Pezalla, E., Fung, S., Takiya, L., Napatalung, L.
Journal: Journal of Managed Care and Specialty Pharmacy, 2023, 29(7), pp. 848–856
Overview: This review addresses the implications of alopecia areata from a managed care perspective, discussing treatment options, economic considerations, and the importance of awareness among payer stakeholders regarding the condition.
Citations: 1

4. Impact of Crisaborole on Sleep Outcomes in Pediatric Patients

Authors: Fowler, J., Sugarman, J., Sher, L., Marfo, A.A., Takiya, L.
Journal: Dermatology and Therapy, 2023, 13(4), pp. 951–960
Overview: This study assesses the effects of Crisaborole, a topical medication, on sleep quality in pediatric patients with mild-to-moderate atopic dermatitis. The findings suggest that treatment with Crisaborole may lead to improved sleep outcomes in this demographic.
Citations: 2

5. Scalp, Eyebrow, and Eyelash Hair Regrowth with Continued Ritlecitinib Treatment

Authors: Senna, M., Forman, S., Bordone, L., Ahmed, H.M., Takiya, L.
Journal: SKIN: Journal of Cutaneous Medicine, 2023, 7(4), pp. s224
Overview: This post hoc analysis of the ALLEGRO trial examines hair regrowth in specific areas among patients who did not meet target efficacy responses at Week 24. The results indicate that continued treatment with ritlecitinib may still yield positive hair regrowth outcomes in these patients.
Citations: 0

6. Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis by Baseline BMI

Authors: Dikranian, A.H., Gonzalez-Gay, M.A., Wellborne, F., Tatulych, S., Curtis, J.R.
Journal: RMD Open, 2022, 8(1)
Overview: This article analyzes pooled data from phase 3 studies to assess how baseline body mass index (BMI) affects the efficacy of tofacitinib in treating rheumatoid arthritis, emphasizing the need for personalized treatment approaches.
Citations: 12

7. Efficacy and Safety of Tofacitinib by Background Methotrexate Dose

Authors: Kivitz, A.J., FitzGerald, O., Nash, P., Wang, C., Takiya, L.
Journal: Clinical Rheumatology, 2022, 41(2), pp. 499–511
Overview: This post hoc exploratory analysis examines the relationship between background methotrexate dosage and the efficacy and safety of tofacitinib in patients with psoriatic arthritis, aiming to optimize treatment strategies.
Citations: 8

8. Patient and Caregiver Preferences on Treatment Attributes for Atopic Dermatitis

Authors: Ervin, C., Crawford, R., Evans, E., Takiya, L., Myers, D.E.
Journal: Journal of Dermatological Treatment, 2022, 33(4), pp. 2225–2233
Overview: This study investigates the preferences of patients and caregivers regarding treatment characteristics for atopic dermatitis, highlighting the importance of patient-centered approaches in therapeutic decision-making.
Citations: 13

9. Correction to: Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use

Authors: Geng, B., Hebert, A.A., Takiya, L., Sanders, P., Lebwohl, M.G.
Journal: Dermatology and Therapy, 2021, 11(5), pp. 1679
Overview: An erratum correcting previously published results on the long-term efficacy and safety of Crisaborole in patients with mild-to-moderate atopic dermatitis.
Citations: 0

10. Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use

Authors: Geng, B., Hebert, A.A., Takiya, L., Sanders, P., Lebwohl, M.G.
Journal: Dermatology and Therapy, 2021, 11(5), pp. 1667–1678
Overview: This article reviews the long-term use of Crisaborole in patients aged ≥ 2 years with mild-to-moderate atopic dermatitis, assessing both efficacy and safety profiles.
Citations: 6